Jacob Ma-Weaver - 15 Jun 2022 Form 3 Insider Report for ARCA biopharma, Inc. (ORKA)

Signature
/s/ Jacob Ma-Weaver
Issuer symbol
ORKA
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
3
Filing time
21 Jun 2022, 19:40:52 UTC
Next filing
31 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABIO Common Stock 2,580,452 15 Jun 2022 By the Funicular Fund F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABIO Put Option 15 Jun 2022 Common Stock 1,450,000 $2.50 By the Funicular Fund F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 is filed by Jacob Ma-Weaver (the "Reporting Person"). The Reporting Person, the Funciular Fund (the "Fund") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person, the Fund and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F2 Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.